Fundraising Fox
/Companies
Sign in

KemNet

YC S22

Edmonton, CA · Founded 2022 · 2 employees · 1 known investors

Find your way into KemNet

Sign up to see every warm intro you have to KemNet

  • Paths you didn't know you had: your email and LinkedIn already hold routes to the KemNet team. We find them for you
  • 2nd- and 3rd-degree connections: the friend-of-a-friend routes that take hours to manually find through your inbox or LinkedIn
  • Answers now, not in days: momentum is everything in a raise. Skip asking around whether someone knows someone

Days of research, done the moment you sign in, with every route ranked by how warm it is.

Sign up with GoogleAlready have an account? Log in

KemNet provides modified versions of existing pharmaceuticals to pharmacies, tailored for specific patient populations with altered formulations that aim for improved efficacy across indications including sexual dysfunction, hair loss, pain management, weight reduction, and women's health.

Also known as Kemet Group Inc.

E-commerceHealthtechMarketplacesMarketplaceB2BDigital HealthTherapeuticsCanadaAmerica / CanadaFully Remote

Founders & leadership· Y Combinator alumni (S22)

KemNet was founded in 2022 by Morẹ́nikẹ́ Ọláòṣebìkan.

MỌMorẹ́nikẹ́ Ọláòṣebìkan
Morẹ́nikẹ́ ỌláòṣebìkanFounderMorẹ́nikẹ́ Ọláòṣebìkan holds a clinical pharmacy license and runs a pharmacy business. She works as a clinical academic colleague at the University of Alberta's Faculty of Pharmacy & Pharmaceutical Sciences and is developing a platform to provide reformulated medications to pharmacies for targeted patient populations.

Investors · 1

Related companies · 5

SafeBeatSafeBeat uses engineering and machine learning to develop solutions for cardiac care and arrhythmia management. The company serves cardiologists, electrophysiologists, and healthcare organizations.
SynsoryBioSynsoryBio develops protein-based drugs that detect their location in the body and activate only at diseased tissue, with applications across cancer and autoimmune conditions.
Promakhos TherapeuticsPromakhos Therapeutics develops immunomodulatory therapies to restore immune system balance and reduce chronic inflammation in diseases like Crohn's disease, ankylosing spondylitis, and psoriasis. The company targets patients with inflammatory diseases who do not benefit from current immunosuppressive treatments.
Eris BiotechEris Biotech develops small-molecule drugs designed to block immune suppression mechanisms, allowing the immune system to attack solid tumors; the company is initially focusing on mesothelioma treatments.
Adventris PharmaceuticalsAdventris is a biotechnology company developing cancer immunotherapy treatments.

Companies working in the same space as KemNet.

Legal entities · 1

corporate structure
Kemet Group Inc.

In the news

KemNet 🚀 Because Not All Pills Should Be Swallowed! 💊ycombinator.com · Aug 2022

Frequently asked questions

What does KemNet do?
KemNet provides modified versions of existing pharmaceuticals to pharmacies, tailored for specific patient populations with altered formulations that aim for improved efficacy across indications including sexual dysfunction, hair loss, pain management, weight reduction, and women's health.
Who founded KemNet?
KemNet was founded by Morẹ́nikẹ́ Ọláòṣebìkan in 2022.
Who are KemNet's investors?
KemNet's investors include Y Combinator.
Where is KemNet headquartered?
KemNet is headquartered in Edmonton, CA.